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The Streif in Kitzbühel, Austria, is regarded as the most challen-
ging ski downhill race. It starts with the ‘Mausefalle’ (the mouse-
trap), a stunning, almost vertical jump—the most dangerous in
the whole championship circuit—that propels skiers within
seconds to a rocket speed and a landing compression of over
1000 kg (Fig. 1). Every champion will tell you that you may have
already lost the race with a timorous jump, but you still have not
won it with an intrepid and successful one. Only about 150 of
the 3312 m would have been accomplished, and the rest of the
steep slope is a succession of fall away turns and leaps, many
with limited visibility and on glaring ice.
This month, the Journal publishes two reports from the two
largest congenital databases—the European and the The Society
of Thoracic Surgeons (STS) National ones [1, 2]—and gives the
opportunity to recall the main objectives and limitations of
these registries. In one report, the various methods to enlarge
the right ventricular outﬂow tract (RVOT) in Tetralogy of Fallot
are evaluated, and in the other, an overview of a large spectrum
of congenital procedures with its attendant mortality is given.
The primary goal of the database is to improve the quality of
care and patients’ safety [3]. The congenital database gathers and
monitors the procedures performed in the ﬁeld of congenital
heart defects, and reports their early outcome. This analysis and
the establishment of an average performance set a reliable refer-
ence for individual measurement and should positively impact
on the quality of care. The 30-day mortality rate is the corner-
stone of the outcome. This rate certainly provides important in-
formation regarding an operative risk but, like the Streif initial
jump, remains incomplete in the assessment of the overall
success or beneﬁt of an operation. In many situations, an
increased operative risk is bargained with a better long-term
quality of life and survival. Take the arterial switch, the double
switch or the Bex-Nikaidoh procedure as examples. None of
them would compete favourably in a 30-day mortality with their
technically easier counterparts such as the Senning procedure, a
physiological correction or a Fontan pathway, respectively. Still,
these demanding operations are rightly favoured by expert sur-
geons, because of their proven mid-term and their anticipated
long-term beneﬁts [4, 5]. The same shortcoming arises from
Sarris et al.’s report [2]. Using only the early mortality—without
any reoperation rate—to evaluate the various methods of RVOT
opening can only lead to incomplete and dubious conclusions
that many of us might draw in spite of the repeated warnings
from the investigators. Congenital cardiac surgeons have learned
since long back that the less the myocardium is cut into, the
better the heart will function. The decision regarding the
infundibulum is no longer taken blindly as a ‘rule of school‘ but
is actually dictated by local ﬁndings. With an infundibulum
methodically left intact, many kids would come back for a
second relief of an excessive obstruction [6, 7].
The second drawback of any such registry study is that it does
not account for the temporospatial characteristic of the truth.
The truth in London is already not the one prevailing in Madrid
or in Paris (not to mention the one in less-developed countries)
for many good reasons related to local expertise, facilities and
beliefs and convictions. Likewise, the truth of today will only
partly be valid in the next decade. Consider simply the fate of
the chronic pulmonary insufﬁciency in longstanding Fallot patients.
Not long ago, our reluctance to reoperate on these patients was
great because of a signiﬁcant mortality rate, which was mainly
due to the fact that these procedures were performed too late,
on already exhausted hearts [8]. With better criteria to implant a
valve in the pulmonary position, the mortality rate of these redo
procedures has dropped dramatically [9]. We are now all con-
vinced that a ﬁrst redo on a tired ventricle is more perilous than
a second or third redo on a well functioning one. The booming
of percutaneously implantable valves will also drastically reduce
the need for reoperation [10]. When, on top of that, one consid-
ers that, as a rule, a ventricle tolerates a volume load better than
a pressure load [11], it is difﬁcult to advocate a preference for a
residual signiﬁcant stenosis over a calibrated transannular patch
with some degree of regurgitation. Limiting the evaluation to the
mortality rates of the various methods of the correction of
Tetralogy of Fallot, the information given by the database, is like
giving the ranking of the skiers after the initial jump of the Streif.
Some may appear to be to be in a better position at that time,
but the ultimate winners will be those able to negotiate the sub-
sequent turns and leaps with the straightest line and least im-
pairment. The divergence between the surgical and the ultimate
outcome is certainly less pronounced in an adult database
because the critical ‘surgical jump’ happens much later in the
race, closer to the ﬁnal strides of life.
The second report, which presents the results in congenital
cardiac surgery on both sides of the Atlantic, is perplexing [1].
Courteously, no formal comparison is made, but everyone is
prone to make it (we have not acquired a scientiﬁc mind to not
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use it), and will then be confronted with intriguing facts. The ﬁrst
one will be the difference in the caseload distribution within cat-
egories. In continents where the same incidence of diseases is
expected—and in the absence of an asymmetric distribution of
acquired disease, like rheumatic valve disease could produce—
this difference is difﬁcult to understand. Even more puzzling will
be the analysis of the mortality rates, which are higher (at times
almost doubled) in all categories of procedures in the European
database compared with the STS one. This difference, probably
reaching statistical signiﬁcance, results in a worrisome excess of
deaths in the European cohort. This embarrassing surplus will
surely torment any surgeon on this side of the Atlantic with the
unrelenting question: is the quality of our work, of my work, so
much behind? Some reports from individual European units are
in accordance with the STS predictions and will comfort us
somehow [12, 13]. Certainly, the states in the USA and Canada
have a more homogenous distribution of high-quality surgical
expertise and facilities in congenital heart disease than the
various countries in Europe. Disparities between the eastern and
western blocks probably still exist, but they have been consider-
ably attenuated over the past years and cannot account for the
magnitude of the reported differences in mortality. In a laconic
sentence of the article, it is stipulated that no less than 30% of
the so-called European data stems from other continents. If this
turns out to be true, then the relevance of the adjective
European should eventually be questioned. However, this is only
the slightest problem. For us, the database sets the standards
against which we monitor our results. It helps us identify the
areas of suboptimal performance needing prompt action to
remain within, or regain, accepted limits. By setting the average
standard at an inferior level, borderline units will not timely
undertake these actions, and more children may suffer from un-
satisfactory management. We still have in mind the so-called
Bristol affair. The implicated unit had the surgical results many
had 10–15 years earlier, but, in 1998, it was already prohibitively
high and led to an unprecedented press scandal [14]. Developing
countries are progressing fast, but many units have still not
reached the standards we were working with a decade ago [15].
In an ideal world, the distribution of performances would be
concentrated around a median line with a limited dispersion (a
narrow bell-shaped curve for statisticians). The STS distribution
looks like the ranking of the ﬁrst group (the downhill specialists)
of the Streif competitors, while the European one resembles the
ﬁnal ranking, the one that also includes the slalom specialists
and the amateur skiers.
It is not our intention to contest the usefulness of the data-
base in congenital cardiac surgery. We need it. Simply, its objec-
tives should not be overplayed. The database is an instrument
for everyone to measure his/her own performance and compare
it with colleagues or institutions working under similar condi-
tions. It is not an instrument to denounce the poor performance
of one team or one surgeon, and likewise, it is also not an instru-
ment for praise or advertisement (all too often, we have seen in
congresses surgeons proudly showing their own circle radiating
in the pole position). Finally, it should be used extremely cau-
tiously as an instrument for the evaluation of therapies and
recommendations, because it reﬂects no more than the ranking
after the ﬁrst Streif jump in an often long, tortuous and eventful
‘congenital cardiac life’. If, however—through the process of com-
parison and appropriate reaction—the database was able to prevent,
even if only once, another ‘Bristol affair’, then its justiﬁcation and
objectives would have been more than fully accomplished.
Conﬂict of interest: none declared.
REFERENCES
[1] Jacobs JP, Jacobs ML, Maruszewski B, Lacour–Gayet FG, Tchervenkov CI,
Tobota Z et al. Initial application in the EACTS and STS Congenital Heart
Surgery Databases of an empirically derived methodology of complexity
adjustment to evaluate surgical case mix and results. Eur J Cardiothorac
Surg 2012;42:775–80.
[2] Sarris GE, Comas JV, Tobota Z, Maruszewski B. Results of reparative
surgery for tetralogy of Fallot: data from the European Association for
Cardio-Thoracic Surgery Congenital Database. Eur J Cardiothorac Surg
2012;42:766–74.
[3] Lacour-Gayet F, Clarke D, Jacobs J, Gaynor W, Hamilton L, Jacobs M
et al. The Aristotle score for congenital heart surgery. Semin Thorac
Cardiovasc Surg Pediatr Card Surg Annu 2004;7:185–91.
[4] Hraska V, Mattes A, Haun C, Blaschczok HC, Photiadis J, Murin P et al.
Functional outcome of anatomic correction of corrected transposition of
the great arteries. Eur J Cardiothorac Surg 2011;40:1227–34.
[5] Vouhe PR. Editorial comment corrected transposition of the great arter-
ies: is ‘anatomic’ repair the optimal option? Eur J Cardiothorac Surg
2011;40:1235.
[6] Alexiou C, Chen Q, Galogavrou M, Gnanapragasam J, Salmon AP,
Keeton BR et al. Repair of Tetralogy of Fallot in infancy with a trans-
ventricular or a transatrial approach. Eur J Cardiothorac Surg 2002;22:
174–83.
[7] Bove T, Francois K, Van De Kerckhove K, Panzer J, De Groote K, De Wolf
D et al. Assessment of a right-ventricular infundibulum-sparing approach
in transatrial-transpulmonary repair of Tetralogy of Fallot. Eur J
Cardiothorac Surg 2012;41:126–33.
[8] Dos L, Dadashev A, Tanous D, Ferreira-Gonzalez IJ, Haberer K, Siu SC
et al. Pulmonary valve replacement in repaired Tetralogy of Fallot: deter-
minants of early postoperative adverse outcomes. J Thorac Cardiovasc
Surg 2009;138:553–9.
[9] Buechel ER, Dave HH, Kellenberger CJ, Dodge-Khatami A, Pretre R,
Berger F et al. Remodelling of the right ventricle after early pulmonary
valve replacement in children with repaired Tetralogy of Fallot: assess-
ment by cardiovascular magnetic resonance. Eur Heart J 2005;26:2721–7.
[10] Eicken A, Ewert P, Hager A, Peters B, Fratz S, Kuehne T et al.
Percutaneous pulmonary valve implantation: two-centre experience with
more than 100 patients. Eur Heart J 2011;32:1260–5.
Figure 1: Didier Cuche in the Streif heading for his fourth victory in the
mythic race. The Swiss champion won it one more time in 2012 and beat the
famous record set by the legendary Franz Klammer. Note the ﬁnish line far
below (Courtesy of Didier Cuche).
R. Prêtre / European Journal of Cardio-Thoracic Surgery764
[11] Turina J, Milincic J, Seifert B, Turina M. Valve replacement in chronic
aortic regurgitation. True predictors of survival after extended follow-up.
Circulation 1998;98 (Suppl. 19):II100–6; discussion II6–7.
[12] Arenz C, Asfour B, Hraska V, Photiadis J, Haun C, Schindler E
et al. Congenital heart surgery: surgical performance according to
the Aristotle complexity score. Eur J Cardiothorac Surg 2011;39:
e33–7.
[13] Bojan M, Gerelli S, Gioanni S, Pouard P, Vouhe P. The Aristotle
Comprehensive Complexity score predicts mortality and morbidity after
congenital heart surgery. Ann Thorac Surg 2011;91:1214–21.
[14] Treasure T. Lessons from the Bristol case. More openness–on risks and
on individual surgeons’ performance. BMJ 1998;316:1685–6.
[15] Saxena A. Congenital cardiac surgery in the less privileged regions of the
world. Expert Rev Cardiovasc Ther 2009;7:1621–9.
ED
IT
O
R
IA
L
R. Prêtre / European Journal of Cardio-Thoracic Surgery 765
